E-ISSN 2223-0343

Changes in serum antibody titer following rabies vaccination in the giant panda

Liu SR1*, Lan JC1, Luo L1, Ayala JE1, Hou R1, Feng Y2, Liu L1, Liao L.H1, Huang WJ1, Xu WD2 and Guo HC2

1Sichuan Key Laboratory of Conservation Biology for Endangered Wildlife, Chengdu Resetrch Base of Giant Panda Breeding, Chengdu 610081, Sichuan, People’s Republic of China; 2Institute of Military Veterinary, Academy of Military Medical Sciences, Changchun 130122, Jilin, People’s Republic of China


The aim of the present study was to assess the immune response and safety of a commercially available rabies virus vaccine in the giant panda. Serum antibody titers were measured and recorded during a one-year period post-vaccination. We injected 13 giant pandas with inactivated adjuvant vaccine against the rabies virus produced by NOBIVAC of Netherlands, followed by blood collection for serologic response. Rabies antibody titers were measured over a period of 12 months using the fluorescent antibody virus neutralization (FAVN) test. No adverse reactions were observed. Furthermore, the vaccine was able to elicit a strong immune reaction from recipients of adult groups, and maintain an adequate level of antibody titers for the duration of at least one year.  Panda cubs received vaccines for the first time were 50% (2/4), developed an antibody response post-vaccination. We concluded that this vaccine is safe and effective for use in the giant panda, providing strong protection against exposure to rabies.

Keywords: Giant panda; rabies vaccine; antibody titer
To cite this article: Liu SR, Lan JC, Luo L, Ayala JE, Hou R, Feng Y, Liu L, Liao LH, Huang WJ, Xu WD and Guo HC, 2016. Changes in serum antibody titer following rabies vaccination in the giant panda. Res. Opin. Anim. Vet. Sci., 6(4): 121-125.

Home  |  Archive  |  Instructions  |  Submission  |  Editorial Board  |  Sample Paper

All rights reserved © roavs.com